- ICH GCP
- USA klinikai vizsgálatok nyilvántartása
- Klinikai vizsgálat NCT02839876
Intravenous Versus Oral Acetaminophen in Primary Total Hip Arthroplasty
Comparison of Multimodal Analgesic Regimen With Intravenous Acetaminophen to Standard Oral Multimodal Therapy in Primary Total Hip Arthroplasty: A Randomized Controlled Double Blind Trial
A tanulmány áttekintése
Állapot
Körülmények
Beavatkozás / kezelés
Részletes leírás
This is a single center, prospective, randomized controlled study. 60 subjects will be recruited (see #6 Recruitment and Compensation below). On the day of surgery, subjects will be randomized to receive either the study intervention (intravenous acetaminophen and placebo tablets) or the control intervention (intravenous saline and active acetaminophen tablets). The Investigational Drug Service will prepare each intervention package, which will include one intravenous and one oral medication dose. Only one of these routes will be active (determined by randomization). Subjects will receive doses of both an intravenous and oral study drug every 6 hours in order to maintain blinding, and will receive a total of 4 doses of each (at 0, 6, 12 and 18 hours). The dose of acetaminophen in all cases will be 1000 mg. The volume of intravenous acetaminophen (and saline) will be 100 mL. The oral dose will consist of two (2) tablets of 500 mg each (or two matching placebo tablets).
All subjects will receive a standardized anesthetic regimen for total hip arthroplasty, as follows:
A) Preoperative phase
Subjects will receive the following preoperative multimodal drugs:
- Pregabalin 75 mg PO
- Celecoxib 200 mg PO
- The interventional drugs, both IV and PO . The time that these drugs are administered will be recorded as time zero. Patients will then receive a spinal anesthetic with 12.5 mg of isobaric bupivacaine. No peripheral nerve blocks will be performed.
B) Intraoperative phase All subjects will be receive propofol infusion beginning at 50 mg/kg/min and titrated to a Richmond Agitation-Sedation Scale score of -1 to -3 (drowsy to moderate sedation). Dexamethasone 10 mg IV and ketamine 0.25 mg/kg IV up to 40 mg total will be administered as part of the standard multimodal regimen. If required, subjects may receive fentanyl 25 mcg IV as needed to treat discomfort. No joint infiltration will be performed by the surgeon.
C) Postoperative phase In the Post-Anesthesia Care Unit (PACU), subjects will have an intravenous patient-controlled analgesia (IVPCA) device connected and loading doses of hydromorphone administered by the PACU nurse as necessary (0.2 mg q 8 min prn).
On the floor, subjects will receive:
- Pregabalin 75 mg PO BID until discharge
- Celecoxib 200 mg PO BID until discharge
- Dexamethasone 10 mg IV x 1 on postoperative day 1 (24 hours after the first dose)
- Intravenous patient-controlled analgesia (IVPCA) with hydromorphone (0.2 mg q 8 min).
The remaining 3 intervention packages (IV and PO) will be administered at 6, 12 and 18 hours following the first dose. At time point 24 hours (i.e. the fifth dose of acetaminophen), all subjects will begin to receive 975 mg of oral acetaminophen, continuing every six hours until discharge.
Tanulmány típusa
Beiratkozás (Tényleges)
Fázis
- 4. fázis
Kapcsolatok és helyek
Tanulmányi helyek
-
-
North Carolina
-
Durham, North Carolina, Egyesült Államok, 27710
- Duke University Hospital
-
-
Részvételi kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
Egészséges önkénteseket fogad
Tanulmányozható nemek
Leírás
Inclusion Criteria:
- Patients scheduled for elective, primary total hip replacement for osteoarthritis
- American Society of Anesthesiologists (ASA) Physical Classification I-III
- Weight 50 kg or greater
- Body mass index 18-40 kg/m2
Exclusion Criteria:
- Inability to consent to study
- Inability to speak English
- Pregnancy
- Weight <50 kg
- Revision hip replacement or emergency surgery
- Contraindications to spinal anesthesia: coagulopathy or bleeding diathesis, local infection, allergy to local anesthetics
- Allergies/intolerances/contraindications to any of the multimodal agents: acetaminophen, pregabalin, celecoxib, ketamine, or dexamethasone
- Chronic pain from a separate source other than operative hip
- Daily opioid equivalent use of 30 mg of morphine or greater at time of consent
- History of heart failure
- History of drug or alcohol abuse
- Rheumatoid arthritis
- Uncontrolled anxiety, schizophrenia or other psychiatric disorder that, in the opinion of the investigator, may interfere with the study assessments
- Chronic malnutrition, renal or liver impairment
- Hypersensitivity to acetaminophen or any of its excipients
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Elsődleges cél: Kezelés
- Kiosztás: Véletlenszerűsített
- Beavatkozó modell: Párhuzamos hozzárendelés
- Maszkolás: Négyszeres
Fegyverek és beavatkozások
Résztvevő csoport / kar |
Beavatkozás / kezelés |
---|---|
Kísérleti: Intravenous acetaminophen
Subjects receive 1000 mg acetaminophen IV immediately preoperatively, as well as at 6, 12, and 18 hours postoperatively.
At the same time points, subjects will receive an oral placebo.
|
Subject receives 1 g acetaminophen by the intravenous route every 6 hours for 4 doses beginning in the preoperative holding area.
Más nevek:
|
Aktív összehasonlító: Oral acetaminophen
Subjects receive 1000 mg acetaminophen PO immediately preoperatively, as well as at 6, 12, and 18 hours postoperatively.
At the same time points, subjects will receive an intravenous placebo.
|
Subject receives 1 g acetaminophen by the oral route every 6 hours for 4 doses beginning in the preoperative holding area.
|
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
---|---|---|
24 Hour Opioid Consumption
Időkeret: 24 hours
|
Cumulative dose of hydromorphone consumed in the first 24 hours postoperatively
|
24 hours
|
Másodlagos eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
---|---|---|
Opioid Consumption (Other)
Időkeret: 0-48 hours
|
morphine equivalent units of intravenous and oral opioids
|
0-48 hours
|
Pain Score, as Measured by the 11-point Numeric Rating Scale (NRS-11) (Preoperatively)
Időkeret: preoperatively
|
Pain scores (using NRS-11 scale) with active range of motion of the hip.
Participants rate their pain on an 11-point scale (0=no pain at all, 10=worst imaginable pain).
|
preoperatively
|
Pain Scores, as Measured by the 11-point Numeric Rating Scale (NRS-11) (1 Hour After Arrival to PACU)
Időkeret: 1 hour after arrival to PACU
|
Pain scores (using NRS-11 scale) at rest.
Participants rate their pain on an 11-point scale (0=no pain at all, 10=worst imaginable pain).
|
1 hour after arrival to PACU
|
Pain Score, as Measured by the 11-point Numeric Rating Scale (NRS-11) (8 Hours)
Időkeret: 8 hours
|
Pain scores (using NRS-11 scale) at rest.
Participants rate their pain on an 11-point scale (0=no pain at all, 10=worst imaginable pain).
|
8 hours
|
Pain Score, as Measured by the 11-point Numeric Rating Scale (NRS-11) (24 Hours)
Időkeret: 24 hours
|
Pain scores (using NRS-11 scale) at rest.
Participants rate their pain on an 11-point scale (0=no pain at all, 10=worst imaginable pain).
|
24 hours
|
Pain Score, as Measured by the 11-point Numeric Rating Scale (NRS-11) (36 Hours)
Időkeret: 36 hours
|
Pain scores (using NRS-11 scale) at rest.
Participants rate their pain on an 11-point scale (0=no pain at all, 10=worst imaginable pain).
|
36 hours
|
Pain Score, as Measured by the 11-point Numeric Rating Scale (NRS-11) (48 Hours)
Időkeret: 48 hours
|
Pain scores (using NRS-11 scale) at rest.
Participants rate their pain on an 11-point scale (0=no pain at all, 10=worst imaginable pain).
|
48 hours
|
Subject Satisfaction at 24 Hours
Időkeret: 24 hours
|
Overall subject satisfaction with hospital experience at the 24 hour time point using a simple 11-point Likert scale to quantify global satisfaction.
0=completely unsatisfied, 10=completely satisfied.
|
24 hours
|
Subject Satisfaction at 48 Hours (48 Hours)
Időkeret: 48 hours
|
Overall subject satisfaction with hospital experience at the 48 hour time point using a simple 11-point Likert scale to quantify global satisfaction.
0=completely unsatisfied, 10=completely satisfied.
|
48 hours
|
Straight Leg Raise
Időkeret: Postoperative day 1
|
Number of participants who are able to complete the active straight leg test.
The subject rests supine and is asked to lift his/her operative lower limb (with knee extended) until the ankle is 20 cm from level.
If the subject can do this, the test is positive.
|
Postoperative day 1
|
Heel Slide Test
Időkeret: Postoperative day 1
|
Number of participants who are able to complete the heel-slide test.
The subject rests supine and is asked to place the heel of his/her operative side on the contralateral knee, then slide the heel down to the ankle and back in one continuous motion.
If the subject can do this, the test is positive.
If the subject cannot do this in one motion, or if pain or other factors prevent the test from being performed, the test is negative.
|
Postoperative day 1
|
Number of Participants Able to Complete the Supine to Sit Test
Időkeret: Postoperative day 1
|
Number of participants able to go from supine to a sitting position independently.
|
Postoperative day 1
|
Self-paced Walk Test
Időkeret: Postoperative day 1
|
Time taken to walk down a hallway 20 m at a safe and quick pace, turn around and return to starting point.
|
Postoperative day 1
|
Number of Participants With Opioid-related Adverse Events
Időkeret: 0-72 hours
|
Incidence of respiratory desaturation events, nausea, vomiting, pruritis, ileus, and constipation
|
0-72 hours
|
Analgesic Consumption as Measured by Patient Diary
Időkeret: day 30
|
morphine equivalent units of oral opioids and other non-opioids
|
day 30
|
Worst Pain (Day 30)
Időkeret: day 30
|
Participants are asked to rate their WORST pain on POSTOPERATIVE DAY 30 on an 11-point scale (0=no pain at all, 10=worst imaginable pain).
|
day 30
|
Pain Score, as Measured by the 11-point Numeric Rating Scale (NRS-11) (Preoperatively)
Időkeret: preoperatively
|
Pain scores (using NRS-11 scale) at rest.
Participants rate their pain on an 11-point scale (0=no pain at all, 10=worst imaginable pain).
|
preoperatively
|
Pain Scores, as Measured by the 11-point Numeric Rating Scale (NRS-11) (1 Hour After Arrival to PACU)
Időkeret: 1 hour after arrival to PACU
|
Pain scores (using NRS-11 scale) at with active range of motion of the hip.
Participants rate their pain on an 11-point scale (0=no pain at all, 10=worst imaginable pain).
|
1 hour after arrival to PACU
|
Pain Score, as Measured by the 11-point Numeric Rating Scale (NRS-11) (8 Hours)
Időkeret: 8 hours
|
Pain scores (using NRS-11 scale) with active range of motion of the hip.
Participants rate their pain on an 11-point scale (0=no pain at all, 10=worst imaginable pain).
|
8 hours
|
Pain Score, as Measured by the 11-point Numeric Rating Scale (NRS-11) (24 Hours)
Időkeret: 24 hours
|
Pain scores (using NRS-11 scale) with active range of motion of the hip.
Participants rate their pain on an 11-point scale (0=no pain at all, 10=worst imaginable pain).
|
24 hours
|
Pain Score, as Measured by the 11-point Numeric Rating Scale (NRS-11) (36 Hours)
Időkeret: 36 hours
|
Pain scores (using NRS-11 scale) with active range of motion of the hip.
Participants rate their pain on an 11-point scale (0=no pain at all, 10=worst imaginable pain).
|
36 hours
|
Subject Satisfaction at 48 Hours
Időkeret: 48 hours
|
Overall subject satisfaction with hospital experience at the 48 hour time point using a simple 11-point Likert scale to quantify global satisfaction.
0=completely unsatisfied, 10=completely satisfied.
|
48 hours
|
Pain Score, as Measured by the 11-point Numeric Rating Scale (NRS-11) (48 Hours)
Időkeret: 48 hours
|
Pain scores (using NRS-11 scale) with active range of motion of the hip.
Participants rate their pain on an 11-point scale (0=no pain at all, 10=worst imaginable pain).
|
48 hours
|
Egyéb eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
---|---|---|
Hospital Length of Stay
Időkeret: 0-72 hours
|
Time to both discharge readiness and to actual discharge
|
0-72 hours
|
Overall Hospital Admission Costs
Időkeret: 0-72 hours
|
difference in total hospital admission cost between groups
|
0-72 hours
|
Pharmacy-related Costs
Időkeret: 0-72 hours
|
difference in pharmacy-related cost between groups
|
0-72 hours
|
Costs Related to Opioid-related Adverse Events
Időkeret: 0-72 hours
|
difference in cost related to treatment of opioid-related adverse events (nausea, vomiting, pruritis, constipation, respiratory depression, dizziness) between groups
|
0-72 hours
|
Cost Associated With Nursing Interventions and Drugs to Treat Opioid-related Adverse Events
Időkeret: 0-72 hours
|
mean cost (per patient) related to nursing care of opioid-related adverse events (nausea, vomiting, pruritis, constipation, respiratory depression, dizziness) in $USD
|
0-72 hours
|
Együttműködők és nyomozók
Szponzor
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Tényleges)
Elsődleges befejezés (Tényleges)
A tanulmány befejezése (Tényleges)
Tanulmányi regisztráció dátumai
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Becslés)
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
További vonatkozó MeSH feltételek
Egyéb vizsgálati azonosító számok
- Pro00072610
Terv az egyéni résztvevői adatokhoz (IPD)
Tervezi megosztani az egyéni résztvevői adatokat (IPD)?
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
az Egyesült Államokban gyártott és onnan exportált termék
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .
Klinikai vizsgálatok a Osteoarthritis
-
Sanford HealthAktív, nem toborzóTérd Osteoarthritis | Csípőízületi gyulladás | Váll osteoarthritis | Boka osteoarthritis | Csukló osteoarthritisEgyesült Államok
-
Medical University of WarsawIsmeretlenOsteoarthritis | Térd Osteoarthritis | Csípőízületi gyulladás | Glenohumeralis osteoarthritisLengyelország
-
Medical University of WarsawIsmeretlenOsteoarthritis | Térd Osteoarthritis | Csípőízületi gyulladás | Glenohumeralis osteoarthritisLengyelország
-
Mitsubishi Tanabe Pharma CorporationBefejezveOsteoarthritis, térd / osteoarthritis, csípőJapán
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsToborzásTérd Osteoarthritis | Osteoarthritis, térd | Krónikus térdfájdalom | A térdízület artropátiája | Térd Betegség | Osteoarthritis Knees Mindkettő | Osteoarthritis térd bal | Osteoarthritis térd jobbEgyesült Államok
-
Joint AcademyLund UniversityToborzásKézi osteoarthritis | Hüvelykujj Osteoarthritis | Csukló osteoarthritis | Ujj osteoarthritisSvédország
-
Toufiqe-E-EalahiToborzás
-
Kaohsiung Veterans General Hospital.Még nincs toborzás
-
Indiana Hand to Shoulder CenterCTM BiomedicalAktív, nem toborzóVáll osteoarthritis | Osteoarthritis váll | Glenohumeralis osteoarthritisEgyesült Államok
-
Fidia Pharma USA Inc.BefejezveTérd Osteoarthritis | Osteoarthritis, térd | Patellofemoralis osteoarthritisEgyesült Államok